enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Metabolic dysfunction–associated steatotic liver disease

   en.wikipedia.org/wiki/Metabolic_dysfunction...

   Metabolic dysfunction–associated steatotic liver (MASL), Metabolic dysfunction-associated steatohepatitis (MASH) [4] [5] Causes: Genetic, environmental: Risk factors: Obesity, metabolic syndrome, type 2 diabetes mellitus, liver disease: Diagnostic method: Ultrasound, Coexisting metabolic disorders, Liver biopsy: Treatment: Weight loss (in ...

3. Steatohepatitis - Wikipedia

   en.wikipedia.org/wiki/Steatohepatitis

   Alcohol-associated (Alcohol-related) Liver Disease (ALD) Risk factors for MASLD include diabetes, obesity and metabolic syndrome. When inflammation is present it is referred to as alcoholic steatohepatitis and nonalcoholic (metabolic dysfunction associated) steatohepatitis (MASH, previously NASH). [2]

4. Fatty liver disease - Wikipedia

   en.wikipedia.org/wiki/Fatty_liver_disease

   Non-alcoholic steatohepatitis (NASH) Alcoholic liver disease (ALD). [1] In 2023, a new nomenclature was chosen, [5] [7] with the classifications including: Metabolic dysfunction–associated steatotic liver disease (MASLD), including: Metabolic dysfunction-associated steatohepatitis (MASH) Metabolic and alcohol associated liver disease (metALD).

5. Viking Therapeutics Garners Analyst Support For NASH And ...

   www.aol.com/viking-therapeutics-garners-analyst...

   On Tuesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) highlighted the final results from its VOYAGE Phase 2b trial of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH ...

6. 89bio to Present New Analyses from ENLIVEN Phase 2b ...

   lite.aol.com/tech/story/0022/20241015/9256122.htm

   About metabolic dysfunction-associated steatohepatitis (MASH) MASH, also known as nonalcoholic steatohepatitis (NASH), is a chronic and progressive condition that represents a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD). It is characterized by fat accumulation in the liver, which causes inflammation and can ...

7. Aligos Therapeutics Presents Positive Data at The Liver ...

   lite.aol.com/tech/story/0022/20241119/9275950.htm

   ALG-055009: Potential best-in-class small molecule THR-β for Metabolic Dysfunction-Associated Steatohepatitis (MASH) Format: Oral presentation Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in Liver Fat at Week 12 in Non-cirrhotic MASH Patients in the Ongoing Randomized ...

8. 3 Things You Need to Know if You Buy Viking Therapeutics Today

   www.aol.com/finance/3-things-know-buy-viking...

   Its candidate to treat metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH) just wrapped up its phase 2b clinical trials. Management thinks that the therapy could be the ...

9. 1 Growing Biotech Stock to Buy Today With $1,000 and ... - AOL

   www.aol.com/finance/1-growing-biotech-stock-buy...

   Madrigal makes a medicine called Rezdiffra, which is currently the only approved treatment for metabolic-associated steatohepatitis (MASH, formerly known as NASH) in patients with moderate to ...